Clinerion Partners with Cisiv in Real-World Research
Basel, Switzerland, July 17, 2017 – Clinerion and Cisiv have formed a partnership to offer an approach to observational research by enabling automated data transfer from electronic hospital records (EHRs) to electronic data capture (EDC).
Clinerion’s Patient Recruitment System applies informatics methodologies to extract and interpret information from EHRs, aggregating healthcare information across institutions, and geographies to create one single, comprehensive real-time view.
Clinerion’s ability to screen EHR data, including coded information, data and free text, will integrate with Cisiv’s platform, Baseline Plus, to create a novel formula. The partnering of both companies’ patented technologies will reduce the data entry burden to physicians participating in observational studies, improve data quality, and enable smooth and rapid data collection in real-world settings.
“Working with Clinerion forms an important part of Cisiv's strategy to provide a platform that combines structured prospective data capture with near real-time extraction from a broad range of data sources. Clinerion's innovative technology is a great fit with Cisiv's unique approach to real world data, which is why we are very excited about this new partnership,” says Dominic Farmer, CEO of Cisiv.
“Offering new ways to simplify data collection for studies aligns perfectly with Clinerion’s overall goal of creating new efficiencies in the entire clinical trial process, saving time and costs in the development of new drugs, and speeding up the delivery of new medicines to the patients who need them,” says Ulf Claesson, CEO, Clinerion.
For more information, please contact:
Florence Barkats
Commercial Director
Cisiv, Ltd.
12th Floor, CI Tower, St George’s Square, New Malden, KT3 4HG, United Kingdom
Tel: +44 (0) 208 939 8470
For more information, please contact:
Le Vin Chin
Head of Marketing and Communications
Clinerion Ltd
Margarethenstrasse 47, CH-4053 Basel, Switzerland
Tel.: +41 61 865 60 54
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
